Efficacy and safety of sunitinib on metastatic renal cell carcinoma: A single ... - UroToday PDF Print
UroTodayWe assessed the efficacy and safety of the tyrosine kinase inhibitor sunitinib in Korean patients with metastatic renal cell carcinoma (mRCC).

... read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.